Regulated information

Vétoquinol continues to launch reference products

Lure (France), December 16, 2013 – In line with its strategy of developing products targeting fast-growing markets, the Vétoquinol Group expands its Flexadin® range world-wide and launches Zylkène® in the United States.

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

2013 3rd quarter sales show organic growth

Vétoquinol generated sales of €74.0 million in the 3rd quarter of 2013, a drop of 0.1% based on reported data, and a 4.4% increase at constant exchange rates.

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - august 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

First half Results

2013 Half year results

Half year financial report 2013

2013 Half year Financial Report

The reference products demonstrate solid growth

Lure (France), August 29, 2013 – At its meeting on August 27, 2013, the Vétoquinol S.A. Board of Directors reviewed the Group’s results, and approved the financial statements for the first six months of 2013.

Monthly information regarding the total number of voting rights and shares making of the share capital - july 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »